Welcome Guest | Register / Login

Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)

1. Executive Summary

2. Global Multiple Sclerosis Market: An Overview

3. Global Multiple Sclerosis Market: An Analysis

3.1. Global Multiple Sclerosis Market: Sizing & Growth (Actual & Forecast)
3.2. Number of Multiple Sclerosis Patients Worldwide
3.3. Global Multiple Sclerosis Market: Market Share Analysis

3.3.1. Market Share: By Major Players
3.3.2. United States Vs Rest of the World
3.3.3. Multiple Sclerosis Market: Competitors Share Shift

3.4. Average Revenue per Patient by Region

4. Multiple Sclerosis Market: Country Analysis

4.1. United States: Multiple Sclerosis Market

4.1.1. United States Multiple Sclerosis Market: Sizing and Growth (Actual & Forecast)
4.1.2. Number of MS Patients in the United States

5. Growth Drivers of Multiple Sclerosis Market

6. Company Profiles: Multiple Sclerosis Market

6.1. Teva
6.1.1. Business Description
6.1.2. Financial Analysis
6.1.3. Business Strategies

6.2. Biogen Idec
6.2.1. Business Description
6.2.2. Financial Analysis
6.2.3. Business Strategies

6.3. Merck KGaA
6.3.1. Business Description
6.3.2. Financial Analysis
6.3.3. Business Strategies

6.4. Bayer
6.4.1. Business Description
6.4.2. Financial Analysis
6.4.3. Business Strategies

6.5. Novartis
6.5.1. Business Description
6.5.2. Financial Analysis
6.5.3. Business Strategies

List of Figures

Figure 1: Multiple Sclerosis Diagrammatic Overview
Figure 2: Global Multiple Sclerosis Market Size, 2007-12 (US$ Million)
Figure 3: Global Multiple Sclerosis Market Size Forecast, 2013-18 (US$ Million)
Figure 4: Global Multiple Sclerosis Patients, 2007-12
Figure 5: Global Multiple Sclerosis Patients Forecast, 2013-18
Figure 6: Global Multiple Sclerosis Market, By Major Players, By Value (2012)
Figure 7: Global Multiple Sclerosis Market Share Analysis, By Geography, 2007-12
Figure 8: Global Multiple Sclerosis Competitor Share shift, 2013-16
Figure 9: Average Revenue per Patient, By Region, 2007-2012 (US$ Thousands)
Figure 10: United states Multiple Sclerosis Market, 2007-12 (US$ Million)
Figure 11: United states Multiple Sclerosis Market Forecast, 2013-18 (US$ Million)
Figure 12: United States Multiple Sclerosis Patients, 2007-12
Figure 13: United States Multiple Sclerosis Patients Forecast, 2013-18
Figure 14: Number of Multiple Sclerosis Patients Worldwide, 2010-2016E
Figure 15: Global Healthcare Expenditure, 2007-2012 (US$ Trillion)
Figure 16: Copaxone Sales, By Region, FY'2011-FY'13
Figure 17: Biogen Idec Global Sales, 2008-2012 (US$ Million)
Figure 18: Global Rebif Sales, 2008-2012 (US$ Million)
Figure 19: Merck Rebif Sales, By Region (2012)
Figure 20: Global Betaseron Sales, 2008-2012 (US$ Million)
Figure 21: Bayer's Pharmaceuticals Global Sales, By Region (2012)
Figure 22: Global Extavia Net Sales, 2008-2012 (US$ Million)
Table 1: Most Common Drugs used for Treating Multiple sclerosis
Table 2: Product Sales of Avonex & Tysabri, 2008-12 (US$ Million)
Why http://www.marketreportsonline.com/
Published By :Daedal Research
Price
Live Chat
Live Chat by Comm100